SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): January 27, 2010
CRYO-CELL International, Inc.
(Exact name of registrant as specified in its charter)
| 700 Brooker Creek Blvd., Suite 1800, Oldsmar, FL | 34677 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: (813) 749-2100
Not applicable
(Former name or former address, if changed since last report)
| Delaware | 0-23386 | 22-3023093 | ||
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(IRS Employer Identification No.) |
| Item 5.02. | Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers. |
(b) On January 27, 2010, Cryo-Cell International, Inc. (the “Company”) was informed of the untimely death of director Gaby Goubran, who passed away on January 27, 2010. Mr. Goubran served as a director of the Company since 2002 and will be greatly missed.
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| CRYO-CELL INTERNATIONAL, INC. | ||||||
| (Registrant) | ||||||
| Date: January 28, 2010 | By: | /S/ JILL M. TAYMANS | ||||
| Name: | Jill M. Taymans | |||||
| Title: | Vice President, Finance | |||||
-3-